Discussion
The primary objective of our study was to investigate the association between night-time sleep duration, siesta and long-term all-cause mortality risk in an older Israeli adult population while trying to understand the joint relationship between sleep duration and siesta. We found higher adjusted mortality risk in long NS-siesta, long NS-no siesta and short NS-siesta compared with short NS-no siesta. This finding suggests that 8 hours or shorter sleep without siesta is associated with the lowest risk of all four sleeping patterns examined. Sleep duration was positively and linearly associated with adjusted mortality in cognitively preserved individuals. However, a U-shaped relationship was observed in cognitively impaired individuals, with sleeping less than 7 hours or more than 8 hours associated with increased risk. Siesta was significantly associated with increased mortality among cognitively preserved individuals only. Our study presents a unique perspective on how night-time and daytime sleep behaviours are jointly associated with mortality risk.
Sleep duration and siesta have long been linked to mortality. A meta-analysis conducted by da Silva et al25 involving 27 cohort studies of older adults showed that both short and long sleep duration and daytime napping are associated with increased mortality risk. The joint association of sleep duration and siesta was not assessed. Using data from the UK Biobank (n≈400 000 adults), Tao et al26 found that sleep duration was associated with mortality (risk ratio (RR)=1.25, 95% CI: 1.16 to 1.34, for sleep duration ≤5 hours and RR=1.30, 95% CI: 1.22 to 1.38, for sleep duration ≥9 hours, compared with sleep duration of 7–9 hours). Siesta has also emerged as a risk factor for all-cause and cause-specific mortality,10 11 adjusted for night-time sleep duration. We aimed to assess the joint association of sleep duration and siesta by investigating four distinct sleep patterns. Our results support the prevailing thought that sleep patterns may be a potential marker for poor physical condition.1 2 27
Furthermore, the entire cohort shows a consistent association between night-time sleep duration and mortality risk. An earlier study by Wang et al9 has demonstrated a distinct J-shaped relationship between sleep duration and mortality among younger adults from 21 countries (Israel not included). However, our cohort is much older. Indeed, a linear trend has previously been described among older Israeli adults.28 29 For example, Cohen-Mansfield and Perach,28 analysing data from 1166 participants aged 75–94 years recruited in the late 1980s, reported HRs of 0.98 (95% CI 0.84 to 1.13) for sleep duration shorter than 7 hours and 1.32 (95% CI 1.09 to 1.58) for sleep duration longer than 9 hours compared with 7–9 hours.
We observed distinct exposure–response relationships by cognitive status: while we observed a nearly linear association among cognitively preserved participants, the association among cognitively impaired subjects was non-linear, with the optimal duration set around 7.5 hours of sleep duration. Individuals with cognitive impairment often have disrupted sleep patterns related to neurodegenerative changes.30 Our results suggest that cognitively impaired individuals require a specific amount of sleep to maintain health, while insufficient and excessive sleep duration could increase mortality risk. Alternatively, the observed association could reflect a bidirectional relationship, where cognitive function alters sleep habits.31
Furthermore, we only found an association between siesta and mortality risk in cognitively preserved individuals. Daytime lethargy may be an early sign of subclinical disease progression32 and may be a reliable marker for physical deterioration among cognitively preserved individuals.
Sleep patterns may act as markers and drivers of physical and functional alterations. Certain sleep behaviours, such as longer sleep duration or siesta, may indicate underlying health conditions such as chronic cardiovascular, metabolic and mental health issues,33 as these conditions often lead to fatigue. As we controlled for some of these conditions, the observed associations partly account for these individual factors. Yet, reverse causality cannot be ruled out. Concurrently, alteration in sleep patterns can disrupt physiological processes such as hormonal and metabolic balances,34 35 thereby worsening health outcomes over time. In addition, sleep alterations are associated with poorer lifestyle indicators.36
Social factors have been associated with variations in sleep habits.37 38 Therefore, the results should be contextualised to the uniqueness of the Israeli population.11 28 As the Israeli population comprises Jewish and Arab individuals, we adjusted for ethnicity in our models to account in part for ethnic differences. Additionally, we focused on older adults, as they present a prone population with many mortality risk factors compared with other age groups.39
As the causal nature of the sleep–mortality association is biologically plausible, interventions to sustain optimal sleep duration and daytime wakefulness could reduce the associated risk. A recent target trial emulation study40 has shown that interventions designed to address inappropriate sleep duration can potentially reduce incident cognitive impairment with an RR of 0.88 (95% CI: 0.80 to 0.95), a promising finding for reducing the risk of other adverse outcomes.
An important consideration should be given to sleep duration classification. Indeed, the existing literature lacks a uniform definition, and several classification systems have been used—a methodological flaw that limits the generalisability of these studies. Moreover, the optimal night-time sleep duration definition for adults is between 7 and 9 hours per night per the American Academy of Sleep Medicine and Sleep Research Society,23 a priori considers the relationship between sleep duration and mortality to be J-shaped or U-shaped. However, this is not the case in our cohort. Consequently, we opted to stratify this older Israeli population based on an established cut-off point among older Israelis, which is 8 hours per night.11 29 Nevertheless, we conducted a sensitivity analysis based on the clinically recommended classification, with the results being generally comparable with the primary analysis (online supplemental table 2).
While our study provides important insights, it is essential to consider several limitations. First, our study’s observational nature makes it difficult to establish causality. Second, although we controlled for various potential confounders, including PAL,41 socioeconomic status42 and pre-existing comorbidities, residual confounding is likely due to other unknown or unmeasured factors. Possible confounders are depression and subjective health,24 28 for which we adjusted (online supplemental table 3) without attenuating the observed associations. Data on the potential use of sleep aids, however, were not collected during the interviews, and therefore, we were unable to account for them. Additionally, our reliance on self-reported sleep habits at a singular time may introduce bias due to inaccurate recall or subjective assessment and not account for changes throughout the follow-up period. Recent studies were inconclusive regarding the validity of personal sleep duration assessment, with some showing a correlation between objective measurement and self-reported sleep habits,43 44 suggesting that our data are generally valid, and others showing a discrepancy.45 The quality of self-reported sleep habits can vary depending on cognitive status, posing a challenge among cognitively impaired individuals. However, we tried to mitigate these biases by excluding participants with severe cognitive impairment and adjusting for cognitive function in our multivariable regression models. Information about siesta in our study was also limited, as no data about the duration of daytime napping were available. Furthermore, we did not consider sleep quality, which may contribute to mortality risk.24 26 46 Another possible limiting factor is the potential underpowering of our analysis in the cognitively impaired cohort due to its smaller sample size than the cognitively preserved group. Indeed, future studies should employ a larger sample size in order to analyse sleep habits according to cognitive status or clinically recommended classification with sufficient power. Despite this, the higher mortality rate within the cognitively impaired group yielded a reasonable number of events.
In conclusion, our study unveils an essential aspect of the complex relationship between sleep behaviours and mortality risk in an older Israeli population. We have identified distinct sleep patterns associated with increased mortality risk compared with short night-time sleep without a siesta. We also pointed out cognitive performance as an essential effect modifier of the sleep–mortality relationship. These findings underscore the potential of sleep behaviours as a marker of health and an indicator of adverse outcomes among older adults.